COMPUMED, INC. APPOINTS PHILLIP M. BERMAN, M.D. TO BOARD OF DIRECTORS

LOS ANGELES, Aug. 3, 2004 -- CompuMed, Inc. (CMPD.OB) -- a medical informatics company serving the healthcare community with diagnostic software solutions -- today announced the appointment of Phillip M. Berman, M.D. to its board of directors.

"We are pleased to add Dr. Berman to CompuMed's board," said Robert Stuckelman, the company's founder and chairman. "His business and medical expertise will complement the experience of our existing personnel, and open new opportunities for CompuMed in the rapidly expanding medical imaging industry."

Jerry McLaughlin, CompuMed's CEO added, "I look forward to working closely with Dr. Berman. His in-depth knowledge of the imaging industry coupled with his proven business acumen will help us accelerate our plans to grow CompuMed's business."

Dr. Berman comes to CompuMed's board with experience as a physician, entrepreneur and Fortune 500 senior level executive. His medical accomplishments include founding three successful radiology practices, serving as chairman of three radiology departments, and founding two successful for- profit imaging centers.

Dr. Berman founded CompuRAD, where he served as chairman and CEO, and guided the company from a boot-strap startup through a successful IPO. He then joined Lumisys, where he served as president and CEO, spearheading the repositioning of the company from a medical device manufacturer to a leading provider of Internet-based medical appliances.

While at Lumisys, he also established AuntMinnie.com -- the world's leading Internet portal for medical imaging professionals. When Lumisys and AuntMinnie.com were acquired by Eastman Kodak in December 2000, Dr. Berman joined Kodak's $2.5 billion health imaging business. He served in various senior management roles, including vice-president and managing director of business development for Kodak Health Imaging, and group vice president for growth businesses in Life Sciences and Internet Enterprises.

Dr. Berman graduated cum laude from both Harvard University and the Medical College of Pennsylvania. He completed his residency in radiology at UC San Diego. He lives in Coronado, California with his wife, Judy, and three children.

About CompuMed:

Founded in 1973, CompuMed, Inc. (OTC Bulletin Board: CMPD) is a leading provider of computer-aided telemedicine and diagnostics technology. The company's core products are the OsteoGramŽ and CardioGram systems. The OsteoGram, which is cleared by the FDA for commercial use, is an accurate and precise technology for low-cost osteoporosis testing. The CardioGram system remotely interprets electrocardiograms and is used by private practice, government and corporate healthcare providers nationwide. The CardioGram also has the capability to automatically provide an over-read (i.e., follow-up review) by a cardiologist. CompuMed is headquartered in Los Angeles. Visit CompuMed at www.compumed.net.

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks defined in this document. All such forward-looking statements whether written or oral, and whether made by or on behalf of the Company are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

CONTACT: Erik Deutsch - Tellem Worldwide, +1 (310) 479-6111 x.15, edeutsch@tellem.com